Van Hulzen Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $607K | Sell |
|
|||||
|
2024
Q4 | $418K | Hold |
|
|||||
|
2024
Q3 | $366K | Sell |
|
|||||
|
2024
Q2 | $363K | Hold |
|
|||||
|
2024
Q1 | $367K | Sell |
|
|||||
|
2023
Q4 | $408K | Sell |
|
|||||
|
2023
Q3 | $313K | Hold |
|
|||||
|
2023
Q2 | $380K | Sell |
|
|||||
|
2023
Q1 | $347K | Hold |
|
|||||
|
2022
Q4 | $339K | Hold |
|
|||||
|
2022
Q3 | $298K | Hold |
|
|||||
|
2022
Q2 | $365K | Sell |
|
|||||
|
2022
Q1 | $404K | Sell |
|
|||||
|
2021
Q4 | $372K | Hold |
|
|||||
|
2021
Q3 | $265K | Sell |
|
|||||
|
2021
Q2 | $367K | Sell |
|
|||||
|
2021
Q1 | $333K | Sell |
|
|||||
|
2020
Q4 | $350K | Buy |
|
|||||
|
2020
Q3 | $277K | Buy |
|
|||||
|
2020
Q2 | $272K | Buy |
|